San Francisco-based Wearable Intelligence is just about $500,000 shy of closing a recent equity funding round in support of its mobile computing systems, according to the company’s SEC filing.
Funding Roundup
HealthQuest Capital looks to investments with its new $110M funding round | Medtech funding for the week of August 18, 2014
Second Sight Medical lands French funding for ‘bionic eye’
Second Sight Medical announced this week that it landed a financial contract with the French Ministry of Health to provide funding for the 1st wave of patients in the country to receive treatment with the Argus II vision system.
Claret Medical chases FDA win with $18M Series B for cerebral protection device
Claret Medical said today that it secured up to $18 million in Series B financing it plans to use to make progress toward the U.S. market.
Ocular Therapeutix IPO reaches $75M with over-allotment
Bedford, Mass.-based Ocular Therapeutix (NSDQ:OCUL) raised $74.8 million though its initial public offering after underwriters fully exercised an over-allotment option to snag additional shares.
IPO or bust for emerging medtechs
HealthQuest Capital raises $110M for healthcare investments
HealthQuest Capital is looking to make some moves healthcare with its newly raised $110 million fund, looking for unmet needs in medical devices, diagnostics and information technology.
PCORI dangles $90M in grants for comparative effectiveness research
The Patient-Centered Outcomes Research Institute is looking to dole out $90 million in support for clinical research, the organization announced today.
ElectroCore seeks commercial partners for non-invasive headache tech
ElectroCore said it tapped investment bank Piper Jaffray to help it court potential partners to commercialize the non-invasive vagus nerve stimulation treatment for headaches it’s developing.
Seventh Sense lands $16M for non-invasive blood collection
Massachusetts-based Seventh Sense Biosystems added 3 new investors this month with the closing of its Series B financing round, which brought in $16 million for the the company’s blood sampling devices.
‘Bionic eye’ maker Second Sight files for $32M IPO
Second Sight Medical hopes to raise $32 million through an initial public offering in support of its wearable visual prosthetics.
The company plans to offer shares at $9 apiece, saying it’ll used the proceeds from its IPO to boost sales & marketing, seek regulatory approvals in new regions and work on the next generation of its technology for helping restore vision to the blind.